WPI researchers have used a form of artificial intelligence (AI) to analyze anatomical changes in the brain and predict ...

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

The Alzheimer’s field is being turned on its head as mounting evidence points to the disease beginning outside the brain many ...

“Delaying the onset of Alzheimer’s disease by just five years could cut the incidence rate in half,” said professor Xue Zhong ...

When specialized cells called tanycytes stop working, disease-causing tau proteins build up in the brain. A group of specialized cells play a crucial part in clearing toxic proteins from inside the ...

Two new clinical trials aimed at treating Alzheimer’s disease are starting up at Barrow Neurological Institute.

Accumulation of the protein tau in the brain is one of the hallmarks of Alzheimer's disease. In a paper published in Cell ...

New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a ...

"WashU Medicine introduces new blood test for Alzheimer’s symptom timing" was originally created and published by Medical ...

MMI is starting FDA-approved human trials for its tiny robot to use needles the size of eyelashes to help clear waste from the brains of Alzheimer’s patients.

Advocacy Day at the State House allows groups across South Carolina the chance to meet with lawmakers -- and make change.